Portfolio company
Exact Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an ultrasound-mediated platform for delivering targeted therapies to patients with cancer, neurological conditions and infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sonothera Therapeutics
This company develops a non-viral gene therapy platform using ultrasound and microbubbles to deliver genetic medicines for patients with serious diseases.
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
SonoThera™
This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
Curix
Curix develops a microbubble injection platform and focused ultrasound technology for non-invasive drug delivery across the blood-brain barrier for patients with neurological diseases.
EnClear Therapies
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
Alpheus Medical
This company develops a non-invasive sonodynamic therapy platform using low-intensity ultrasound and tumor-localising drugs to treat patients with glioblastoma and other brain cancers.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
